538 related articles for article (PubMed ID: 27270401)
1. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS.
Park YH; Wood G; Kastner DL; Chae JJ
Nat Immunol; 2016 Aug; 17(8):914-21. PubMed ID: 27270401
[TBL] [Abstract][Full Text] [Related]
2. Control of the innate immune response by the mevalonate pathway.
Akula MK; Shi M; Jiang Z; Foster CE; Miao D; Li AS; Zhang X; Gavin RM; Forde SD; Germain G; Carpenter S; Rosadini CV; Gritsman K; Chae JJ; Hampton R; Silverman N; Gravallese EM; Kagan JC; Fitzgerald KA; Kastner DL; Golenbock DT; Bergo MO; Wang D
Nat Immunol; 2016 Aug; 17(8):922-9. PubMed ID: 27270400
[TBL] [Abstract][Full Text] [Related]
3. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.
Van Gorp H; Saavedra PH; de Vasconcelos NM; Van Opdenbosch N; Vande Walle L; Matusiak M; Prencipe G; Insalaco A; Van Hauwermeiren F; Demon D; Bogaert DJ; Dullaers M; De Baere E; Hochepied T; Dehoorne J; Vermaelen KY; Haerynck F; De Benedetti F; Lamkanfi M
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14384-14389. PubMed ID: 27911804
[TBL] [Abstract][Full Text] [Related]
4. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
Magnotti F; Malsot T; Georgin-Lavialle S; Abbas F; Martin A; Belot A; Fauter M; Rabilloud M; Gerfaud-Valentin M; Sève P; Duquesne A; Hot A; Durupt S; Savey L; Giurgea I; Grateau G; Henry T; Jamilloux Y
Ann Rheum Dis; 2021 Jan; 80(1):128-132. PubMed ID: 33037005
[TBL] [Abstract][Full Text] [Related]
5. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
[TBL] [Abstract][Full Text] [Related]
6. The Pyrin Inflammasome in Health and Disease.
Schnappauf O; Chae JJ; Kastner DL; Aksentijevich I
Front Immunol; 2019; 10():1745. PubMed ID: 31456795
[TBL] [Abstract][Full Text] [Related]
7. Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations.
Sugiyama R; Agematsu K; Migita K; Nakayama J; Mokuda S; Ogura F; Haraikawa K; Okumura C; Suehiro S; Morikawa S; Ito Y; Masumoto J
Mol Biol Rep; 2014 Jan; 41(1):545-53. PubMed ID: 24318677
[TBL] [Abstract][Full Text] [Related]
8. Pyrin Inflammasome Activation Abrogates Interleukin-1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis.
Mortensen SB; Hansen AE; Mogensen TH; Jakobsen MA; Beck HC; Harvald EB; Lambertsen KL; Johansen IS; Andersen DC
Arthritis Rheumatol; 2021 Nov; 73(11):2116-2126. PubMed ID: 33913256
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation.
Chirita D; Bronnec P; Magnotti F; Dalmon S; Martin A; Popoff M; Gerfaud-Valentin M; Sève P; Belot A; Contis A; Duquesne A; Nocturne G; Lemelle I; Georgin-Lavialle S; Boursier G; Touitou I; Jamilloux Y; Henry T
Cell Death Dis; 2023 Mar; 14(3):213. PubMed ID: 36966139
[TBL] [Abstract][Full Text] [Related]
10. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients.
Magnotti F; Lefeuvre L; Benezech S; Malsot T; Waeckel L; Martin A; Kerever S; Chirita D; Desjonqueres M; Duquesne A; Gerfaud-Valentin M; Laurent A; Sève P; Popoff MR; Walzer T; Belot A; Jamilloux Y; Henry T
EMBO Mol Med; 2019 Nov; 11(11):e10547. PubMed ID: 31589380
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever.
Repa A; Bertsias GK; Petraki E; Choulaki C; Vassou D; Kambas K; Boumpas DT; Goulielmos G; Sidiropoulos P
Hum Immunol; 2015 Jul; 76(7):488-95. PubMed ID: 26074413
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional licensing is required for Pyrin inflammasome activation in human macrophages and bypassed by mutations causing familial Mediterranean fever.
Mangan MSJ; Gorki F; Krause K; Heinz A; Pankow A; Ebert T; Jahn D; Hiller K; Hornung V; Maurer M; Schmidt FI; Gerhard R; Latz E
PLoS Biol; 2022 Nov; 20(11):e3001351. PubMed ID: 36342970
[TBL] [Abstract][Full Text] [Related]
13. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF.
Karacan İ; Uğurlu S; Tolun A; Tahir Turanlı E; Ozdogan H
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):75-81. PubMed ID: 29148404
[TBL] [Abstract][Full Text] [Related]
14. Function and mechanism of the pyrin inflammasome.
Heilig R; Broz P
Eur J Immunol; 2018 Feb; 48(2):230-238. PubMed ID: 29148036
[TBL] [Abstract][Full Text] [Related]
15. Overlap of familial Mediterranean fever and hyper-IgD syndrome in an Arabic kindred.
Moussa T; Aladbe B; Taha RZ; Remmers EF; El-Shanti H; Fathalla BM
J Clin Immunol; 2015 Apr; 35(3):249-53. PubMed ID: 25708585
[TBL] [Abstract][Full Text] [Related]
16. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.
Park YH; Remmers EF; Lee W; Ombrello AK; Chung LK; Shilei Z; Stone DL; Ivanov MI; Loeven NA; Barron KS; Hoffmann P; Nehrebecky M; Akkaya-Ulum YZ; Sag E; Balci-Peynircioglu B; Aksentijevich I; Gül A; Rotimi CN; Chen H; Bliska JB; Ozen S; Kastner DL; Shriner D; Chae JJ
Nat Immunol; 2020 Aug; 21(8):857-867. PubMed ID: 32601469
[TBL] [Abstract][Full Text] [Related]
17. Recent Insights in Pyrin Inflammasome Activation: Identifying Potential Novel Therapeutic Approaches in Pyrin-Associated Autoinflammatory Syndromes.
Wouters F; Bogie J; Wullaert A; van der Hilst J
J Clin Immunol; 2023 Dec; 44(1):8. PubMed ID: 38129719
[TBL] [Abstract][Full Text] [Related]
18. CDC42 regulates PYRIN inflammasome assembly.
Spel L; Zaffalon L; Hou C; Nganko N; Chapuis C; Martinon F
Cell Rep; 2022 Nov; 41(7):111636. PubMed ID: 36384121
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism.
Magnotti F; Chirita D; Dalmon S; Martin A; Bronnec P; Sousa J; Helynck O; Lee W; Kastner DL; Chae JJ; McDermott MF; Belot A; Popoff M; Sève P; Georgin-Lavialle S; Munier-Lehmann H; Tran TA; De Langhe E; Wouters C; Jamilloux Y; Henry T
Cell Rep; 2022 Oct; 41(2):111472. PubMed ID: 36223753
[TBL] [Abstract][Full Text] [Related]
20. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.
Sharma D; Malik A; Guy C; Vogel P; Kanneganti TD
J Clin Invest; 2019 Jan; 129(1):150-162. PubMed ID: 30457980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
